OR WAIT null SECS
January 12, 2017
January 10, 2017
The membrane-based Protein A purification tool was unveiled at the 2017 PepTalk Conference in San Diego, California.
Language surrounding regenerative medicine and the REGROW Act appeared back into the 21st Century Cures Act right before it passed. What will this mean for the controversial testing and marketing of stem-cell therapies?
January 09, 2017
The companies will combine expertise on T-cell therapies with two or more binding domains to create novel oncology medications.
The partnership will focus on providing practical information to clients on the development of biologics and vaccines.
January 02, 2017
FDA plans to advance initiatives for ensuring reliable production of drugs and biologics in 2017.
Analytical technologies play a key role in the characterization and quantitation of oligonucleotide therapeutics.
December 19, 2016
A pilot project, beginning in 2017, will support the development of biosimilars.
December 16, 2016
Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.
December 15, 2016
Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.